Prothrombin 20210G>A genotype and C-reactive protein level

Blood

Volumn 118, Issue 16, 2011, Pages 4495-4496

  Hoppe, Berthold ^a   Burmester, Gerd Rüdiger ^a   Häupl, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARRIER PROTEIN; PROTHROMBIN;

ADULT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; GENOTYPE; HUMAN; INFLAMMATION; INFORMED CONSENT; LETTER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; OBSERVATIONAL STUDY; PLACENTA DISORDER; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANK SUM TEST; REPRODUCTION; RISK; STANDARDIZATION; STANDARDIZED INCIDENCE RATIO; STUDENT T TEST; UNIVARIATE ANALYSIS; VARIANCE; VENOUS THROMBOEMBOLISM; WILD TYPE;

EID: 80054840645     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-08-373928     Document Type: Letter

References (8)

1. Chen D, Dorling A. Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost. 2009;7 Suppl 1:122-126.
2. Flick MJ, Chauhan AK, Frederick M, et al. The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A. Blood. 2011;117(23):6326-6337.
3. Gehring NH, Frede U, Neu-Yilik G, et al. Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet. 2001;28(4):389-392.
4. von Versen-Hoeynck FM, Hubel CA, Gallaher MJ, Gammill HS, Powers RW. Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia. Am J Hypertens. 2009;22(6):687-692.
5. Ernst GD, de Jonge LL, Hofman A, et al. C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: the Generation R Study. [published online ahead of print April 8, 2011]. Am J Obstet Gynecol. doi: 2011;10.1016/j.ajog. 2011.03.049.
6. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein and risk of venous thromboembolism in the general population. Arterioscler Thromb Vasc Biol. 2010;30(8):1672-1678.
7. Karakas M, Baumert J, Greven S, Ruckerl R, Peters A, Koenig W. Reproducibility in serial C-reactive protein and interleukin-6 measurements in postmyocardial infarction patients: results from the AIRGENE study. Clin Chem. 2010;56(5):861-864.
8. Hoppe B, Heymann GA, Koscielny J, Hellstern P, Kiesewetter H, Salama A. Screening for multiple hereditary hypercoagulability factors using the amplification refractory mutation system. Thromb Res. 2003;111(1-2):115-120. (Pubitemid 37485935)